4-Dimethylaminobenzylamine as a sensitive chemiluminescence derivatization reagent for 5-hydroxyindoles and its application to their quantification in human platelet-poor plasma

The Measurement of Platelet-Poor Plasma Serotonin: A Systematic Review of Prior Reports and Recommendations for Improved Analysis

BACKGROUND

Recent reports of new and important roles for serotonin (5-hydroxytryptamine, 5-HT) in the periphery have substantially increased interest in measuring peripheral serotonin. Nearly all circulating serotonin is found within platelets and this pool has been assessed by measuring serotonin in whole blood or in platelet-rich plasma. Measurement of the much smaller but potentially critically important pool of human free plasma serotonin in platelet-poor plasma (PPP) has proven much more difficult, with a wide range of reference values reported.

CONTENT

To characterize the available data we carried out a systematic literature search of previous reports of PPP serotonin and attempted to determine the best estimate of true PPP serotonin concentration in humans. A total of 101 published reports that included PPP serotonin values in healthy controls were found and included in the summary statistical analyses. The distribution of PPP serotonin values demonstrated high skewness (+1.98), and the reported values ranged from 0.6 to 179 nmol/L, with a mean of 31.6 nmol/L, an SD of 38.9 nmol/L, and a median of 14.8 nmol/L.

SUMMARY

Reported concentrations for human PPP or free plasma serotonin were highly discrepant, with most reports giving erroneously high values that should be disregarded. Inherent difficulties in selectively measuring the extremely low concentrations of serotonin present in PPP and in preparing PPP without contamination from platelet-derived serotonin contributed to the problem, as did the failure of researchers to compare their results with those from prior studies. There is a clear and pressing need for reference materials for the measurement of plasma (PPP) serotonin.

Use of tris(2,2'-bipyridine)osmium as a photoluminescence-following electron-transfer reagent for postcolumn detection in capillary high-performance liquid chromatography

The photoluminescence-following electron-transfer (PFET) technique, developed in our laboratory, is a sensitive chromatographic detection method for oxidizable analytes. Because the oxidations are homogeneous, the technique avoids the problem of electrode fouling. A liquid-phase oxidant reacts with the electrochemically active analytes after separation, becoming capable of photoluminescence. Laser-induced photoluminescence is measured to quantitate the analytes. Thus, the electrochemical properties of the oxidant determine the detection selectivity, and the spectroscopic properties define the sensitivity. The properties of tris(2,2'-bipyridine)osmium (1) were investigated for use as the liquid-phase oxidant in the PFET system. The redox potential of the complex is less positive than that of tris(2,2'-bipyridine)ruthenium (2); thus, on-line generation of 1(3+) by reaction with PbO2, and selective oxidation of catechols by 1(3+), was possible. The mild oxidizing power of 1(3+) led to a lower background signal (compared to 2(3+)) when mixed with acidic mobile phases. Photoluminescence from 1(2+) was much weaker than that from 2(2+); nonetheless, the system achieved subnanomolar detection limits for dopamine, 3-methoxytyramine, and serotonin. Dopamine and 3-methoxytyramine in rat brain striatal dialysates were determined before and after the injection of nomifensine. The pH of the mobile phase can govern the detection selectivity, since oxidation of most organics is accompanied by proton transfer. Reaction of 1 with catechols showed pH-dependent sensitivity resulting from pH-dependent reaction rate changes. Since the reaction rate is also temperature dependent, increased temperature at the mixer resulted in higher sensitivity. However, the noise level also increased at elevated temperature; thus, the detection limit did not improve.

Statistical and Generalized Two-Dimensional Correlation Spectroscopy of Multiple Ionization States. Fluorescence of Neurotransmitter Serotonin

Fluorescence spectra of neurotransmitter serotonin are analyzed with generalized and statistical two-dimensional correlation spectroscopy. A comparison is provided for these two emerging data analysis techniques. Both methods reveal correlations between spectral variables and demonstrate enhanced sensitivity in detecting the dynamic spectral changes over conventional one-dimensional spectroscopy. Both statistical and generalized 2D correlation analysis emphasize simultaneous spectral changes in response to external perturbations. Generalized 2D correlation spectroscopy further reveals the difference in rates of these dynamic changes. Using 2D correlation analysis, a third ionization species of serotonin is identified using pH and excitation wavelength perturbation. This species is a doubly deprotonated serotonin with very low fluorescence quantum yield, confirmed by using a laser excitation at longer wavelength and at higher pH. Taking advantage of the spectral differences between excitation of serotonin and tryptophan, as low as 3.8 nM serotonin can be detected in the presence of 20 microM tryptophan, with long-wavelength excitation. This represents the sensitive detection of serotonin in 5000-fold excess of tryptophan.

HPLC of tryptophan and its metabolites: as OPA derivatives and on the basis of their UV and fluorescence spectra, simultaneously

A HPLC method was developed for the quantitation of tryptophan and its metabolites, in total sixteen compounds, belonging both to the indolyl and kynurenine pathways. Primary amino group containing metabolites have been quantitated as their o-phthaldialdehyde/3-mercaptopropionic acid derivatives (5-hydroxytryptophan, tryptophan, 5-hydroxytryptamine, tryptamine), others without derivatization (quinolinic-, nicotinic-, antranilic-, xanthurenic-, kynurenic, indoleacetic- and indolepropionic acids, nicotineamide, melatonin, tryptophol, indole, methyl-indole), in a single run, within 20 min. Fluorescence and UV detections were performed simultaneously.

5-hydroxytryptophol as a marker for recent alcohol intake

AIMS

To review the mechanism behind the alcohol-induced shift in serotonin metabolism, and the use of urinary 5-hydroxytryptophol (5-HTOL) as a biochemical marker of acute alcohol consumption.

BACKGROUND

The serotonin metabolite 5-HTOL is a normal, minor constituent of urine and is excreted mainly in conjugated form with glucuronic acid. The formation of 5-HTOL increases dramatically after alcohol intake, due to a metabolic interaction, and the elevated urinary excretion remains for some time (>5-15 hours depending on dose) after ethanol has been eliminated. This biochemical effect can be used for detection of recent alcohol intake.

RESULTS

5-HTOL is determined by the gas chromatography-mass spectrometry (GC-MS) or liquid chromatography and mass spectrometry (LC-MS) techniques. A new ELISA method for 5-HTOL glucuronide provides a promising clinical assay. The most robust way to use the marker is by measuring the ratio of 5-HTOL to 5-hydroxyindoleacetic acid, because this compensates for urine dilution and dietary intake of serotonin. 5-HTOL is a very sensitive and specific indicator of recent alcohol consumption and, as such, a valuable complement to self-report. In clinical use, 5-HTOL is effective for monitoring lapses into drinking during out-patient treatment and for objective evaluation of treatment efforts. Other applications include detection of high-risk patients in elective surgery, monitoring of disulfiram treatment and a method to rule out artefactual ethanol formation in forensic toxicology. 5-HTOL can also be used as a sensitive reference method for validation of self-report data in clinical alcohol research.

CONCLUSIONS

An elevated urinary 5-HTOL level can serve as a sensitive and reliable marker for recent alcohol intake with a number of clinical and forensic applications.